chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rapid Heart Rate, Flushing, Hives on upper body, Nausea, Dizzy, feeling faint - This reaction occurred very quickly in approximately 5 minutes.    EMT at site was not  alarmed.  My heartrate decreased, and after my waiting time was over, I went home.  After getting home and sending pictures of rash and list of symptoms to an allergist, I was told to take a double dose of liquid Benadryl and a dose of oral steroids.
Patient was here for the second Moderna vaccine. Tolerated first dose with no reaction. About 10 minutes after receiving the second dose she started her throat felt "tight." Denied any trouble breathing, breathing was not labored, HR and O2 were WNL. After no change in symptoms we administered 50mg of diphenhydramine. 3 minutes after administration patient stated she felt better. Observed patient for an additional 20 minutes after and patient had no further issues. Educated on when to seek emergent care.
Shingles  Symptoms: rash, nerve pain, fatigue.  Valtrex 3 times a day for 7 days.
Dry, red itchy rash on face, chest and 1 leg.  Very red and inflamed. Treated with oral diphenhydramine. Will call MD tomorrow if still present because that will be past the 48 hour mark since symptoms started.
Had shot  still had shingles, shot is 30% effective, Suspected vaccination failure; still had shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 18-FEB-2023: Reporter's comment: This case was reported by a consumer via interactive digital media. The reporter said she had shingles shot and still had Shingles. The reporter said the shot was only 30 percent effective. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow up would not possible, as no contact details were available.
Local rash/red area 3 inch diameter around injection site. Flush to skin, painful. Showed up approximately 3 days post injection.
One day after injection on 5/14/21, got intense painful ache under right ear. It went away after about a day. But then on the evening of 5/24, I found that my right eye was very scratchy. On 5/25, I realized it?s because the right eye would not close all the way. On the evening of 5/25, I found my food kept falling into my right cheek when I ate. On 5/26, I found that my right eye would not blink at all. And my right cheek was numb. My right eyebrow would not raise as high as the left and my smile was crooked. I went to urgent care and they diagnosed me with Bell?s Palsy.
Redness at injection site and redness throughout upper arm, shivering, and swollen lymph node (armpit).
tendonitis like pain in rt arm & shoulder then loss of balance & weakness MRI done showed small stroke-improved w/physical therapy & time off work-cont to have gen arthralgia & myalgia;saw MD;diffuse pain in arm;5% permanent impairment myal
Fever, chills, headache, myalgias beginning evening of 8 Jan 2021.  On 9 Jan 2021, I tested positive PCR for Covid-19.  Quarantined for 10 days.   Negative nasal PCR on 19 Jan 2021.  Symptoms lasted a week.
Administered three doses today - after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Administered three doses today - after temperature excursion) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jul-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Administered three doses today - after temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Administered three doses today - after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
I started having lower back pain across the day after receiving my vaccine; I thought it might've been a bladder infection, but then recalled the same thing happened after my first dose of the vaccine. The day after, I had a fever, chills, and body aches that progressed and occurred again after receiving my booster vaccine. I went to three emergency clinics and received shots of Toradol for pain and prescription for sinus antibiotics for the symptoms I was experiencing. I'm still experiencing the back pains up until this day; in fact, they're even worse.
1/8 vaccination *1-8-1/11 I felt fine 1/12 7am, when i woke up my eye was goopy, sticky, L eye. I could not blink. I noticed more problems later in the day; my mouth wasn't working properly (couldn't eat properly). I tried to call and make appt with PCP.  Informed to go smile in front of mirror, my smile was sagging on L side. Informed to call 911.  TX to hospital,  for possible stroke.   Dr. ran tests Dr. audio / visual consult *diagnosed with Bells Palsy  1/21 started to feel better  **2/5/2021 2nd vaccination
Very sore next day, then as the week went on, It worsened until I could not put on or take of my top.  It hurt to lie on or to use it for anything.  It hurt to hang down by my side.  I tried some prednisone, which helped for a day.  After 4 weeks, I went to an orthopedist and received a cortisone injection in my subacromial bursa.  He said the vaccination went into my bursa and caused an inflammatory reaction.  In talking to my pharmacist, it was the flu vaccine that was the higher up of the two.
Significant area of erythema around vaccine site in about 6 cm in radius. Had raised hardened question of possible 2 times. Erythema was over right bicep/deltoid area.
Dizziness, Myalgia, pain in opposite arm Narrative:  Per nursing report: "took 2nd dose of Moderna vaccine this morning. C/o muscles aching and dizziness. Also c/o left arm pain but states received vaccine on right arm. States not feeling well at all."
rashes on skin, rash is coming and going; hurts with lots of itching; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rashes on skin, rash is coming and going) and PRURITUS (hurts with lots of itching) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001M20A) for COVID-19 vaccination.     no medical history is provided and concomitant drugs are provided.  Concomitant products included FAMOTIDINE for an unknown indication, LOSARTAN and METFORMIN.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced RASH (rashes on skin, rash is coming and going) and PRURITUS (hurts with lots of itching). The patient was treated with DIPHENHYDRAMINE at an unspecified dose and frequency. At the time of the report, RASH (rashes on skin, rash is coming and going) and PRURITUS (hurts with lots of itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Large local reaction with rash. Patient complains ichyness and it is warm to the touch. Mother gave Benadryl and ice yesterday at the start of side of effects. The rash has spread further on day four, when they returned to the clinic.
Pt recv vax 21APR94 & 3 days later devel hives described as a raised red rash, on hands & wrist area; pt seen by MD & was treated w/Atarax; Lab testing on 6JUN94 revealed borderline anti-HBS of 3.8
patient received an extra Moderna Covid-19 vaccine booster dose.; This spontaneous case was reported by a nurse and describes the occurrence of EXTRA DOSE ADMINISTERED (patient received an extra Moderna Covid-19 vaccine booster dose.) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048L21A, 048L21A and 012H21B) for COVID-19 prophylaxis.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Jul-2022, received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXTRA DOSE ADMINISTERED (patient received an extra Moderna Covid-19 vaccine booster dose.). At the time of the report, EXTRA DOSE ADMINISTERED (patient received an extra Moderna Covid-19 vaccine booster dose.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  On 18-Nov-2021, the patient received first booster dose.  On 18-May-2022, the patient received second booster dose.  The reporter was not aware of any adverse reactions or side effects to the first dose. No side effects or adverse reactions were reported after second dose. The patient did not experience any known adverse events or side effects after first booster dose and second booster dose.  The patient received third booster dose on 05-Jul-2022 by mistake. The patient received a third vaccination booster dose where only 2 Moderna Covid-19 vaccination doses had been authorized for the non immunocompromised patient.  The vaccinating provider did not notice that the patient had recived her second Moderna Booster dose.  No other side effects or adverse events have been observed.  Treatment information was not provided.
Patient said that she felt a radiating pain after the injection. It has since subsided. But patient stated that she now has a bruise in that arm.
Red itchy bump at the injection site; Red itchy bump at the injection site; Red itchy bump at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Red itchy bump at the injection site), VACCINATION SITE PRURITUS (Red itchy bump at the injection site) and VACCINATION SITE ERYTHEMA (Red itchy bump at the injection site) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 101A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE MASS (Red itchy bump at the injection site), VACCINATION SITE PRURITUS (Red itchy bump at the injection site) and VACCINATION SITE ERYTHEMA (Red itchy bump at the injection site). At the time of the report, VACCINATION SITE MASS (Red itchy bump at the injection site), VACCINATION SITE PRURITUS (Red itchy bump at the injection site) and VACCINATION SITE ERYTHEMA (Red itchy bump at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Concomitant medication was not provided.
Ear hurting; Tongue "on fire"; A spontaneous report was received from a consumer concerning a 85-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events ear pain, tongue discomfort.  The patient's medical history was not provided. Concomitant medications reported were amoxycillin Antibiotic, Loratadine Antihistamine for drug use for unknown indication.  On 6 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 011L20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 8 Feb 2021, the patient experienced the events ear pain, tongue discomfort.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, ear pain, tongue discomfort was unknown.
I?m having a rash on my arms and thighs, 100 fever, massive headache, and arm hurts bad where the second shot was given.
She experienced slight soreness on day 1 after vaccination. Then she noticed a red area around injection site a few inches.
Entire upper deltoid area of arm became very swollen, red and itchy (border expanded outside of injection site).
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, lot number: unknown), for Covid-19 immunization; Bnt162b2 (DOSE 2, SINGLE, lot number: unknown), for Covid-19 immunization. The following information was reported: PULMONARY EMBOLISM (medically significant), outcome "unknown", described as "Pulmonary embolisms in both lungs"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "Felt bad for many days"; FRUSTRATION TOLERANCE DECREASED (non-serious), outcome "unknown", described as "very frustrated". The patient underwent the following laboratory tests and procedures: investigation: unknown results; scan: unknown results. Therapeutic measures were taken as a result of pulmonary embolism, feeling abnormal, frustration tolerance decreased. Clinical course: "I received both vaccines and a booster. After the booster I felt bad for many days and a few weeks later was diagnosed with pulmonary embolisms in both lungs. I had not had COVID and after many tests and scans, there are no reasons for me to have them. It appears I got them because of the booster. I am very frustrated and could have had a stroke or died. I have spent thousands of dollars for treatment." The lot number for bnt162b2 was not provided and will be requested during follow up.
arm pain spread to pain in same ear as injection, headache, body aches becoming severe, lasted 3 days
COVID+ 12/09/2022  Vaccination status - Moderna x3 No d/c summary available to date: H&P 12/9/22:CHIEF COMPLAINT: Acute respiratory disease due to COVID-19 virus ASSESSMENT / PLAN: * Acute respiratory failure due to COVID-19   Assessment & Plan Patient had COVID at the end of September 2022.  Patient had 3 previous vaccinations.  Reports of shortness of breath since infection.  Worsening shortness of breath on 12/08/2020 to presented to the ER for further evaluation. Home baseline RA, currently requiring 2L with ambulation COVID positive Mild wheezes Plan: Supplemental O2 and continuous pulse ox monitor Ween as able PRN albuterol for wheezing procalcitonin pending, add antibiotic coverage if elevated Increased daily home decadron  Aggressive pulmonary toilet with cough and deep breath/ ICS Monitor daily CMP and CBC Cerebral arteriosclerosis with history of previous stroke Assessment & Plan Previous history of CVA Continue home Lipitor and eliquis Occasionally uses a cane with ambulation at baseline Known word finding difficulties per patient and spouse Atrial fibrillation   Assessment & Plan Rate controlled Continue home anticoagulation COPD (chronic obstructive pulmonary disease) Assessment & Plan Known COPD, worsened since initial COVID infection. Continue home medication. Will increased decadron from 2mg daily to 6mg for short taper.  GERD (gastroesophageal reflux disease) Assessment & Plan Auto sub home Prilosec for Protonix PRN tums Code status: Full resuscitation  Called spouse, and verified patient history, medications, code status and plan of care. All questions were answered at this time.  65 minutes were spent on the unit/floor with the patient with over 50% spent counseling and coordination of care related to disease process and plan of care. Subjective  HISTORY OF PRESENT ILLNESS: Patient is a 84 y.o. male who presents today with increased shortness of breath and cough. Patient reports history of CVA, COPD, and GERD. Patient reports history of COVID infection September 2022 with continued shortness of breath since that time. Patient stated this worsened on 12/8/2022 with increased yellow productive sputum. Due to fatigue, weakness and difficulty breathing patient called EMS for assistance.  EMS gave patient albuterol treatment and IV solumedrol. Patient was transported to ED for further evaluation. Patient's laboratory findings were mostly unremarkable expect with increased ALT, bilirubin and positive COVID detection. Chest xray was completed followed by CT thorax which showed concern for Left lower lobe pneumonia. Upon ambulation, patient had decreased oxygen saturation requiring 2 L nasal canula to maintain oxygen saturation. Patient was given IV rocephin and doxycycline. Admission to the hospitalist service was accepted for continued treatment of acute respiratory failure, LLL pna and COVID support.
Per pt:  I received a 3rd vaccine (Pfizer) on August 18 due to my immune deficiency.  I felt mild symptoms about 24 hours after the shot and they last for 1/2 day.  On the 20th I was fine.  On the 21st and 22nd, I had extreme fatigue and a low grade fever (100.4).  After that I was fine for 6 days.  On Saturday the 28th,  I was again hit with the fatigue, chills and hot flashes.  The 29th was okay, but both yesterday and today have been back to the symptoms again.
Fatigue started late morning 2/17; fleeting low-grade headaches started later on 17th or on 18th.  Fatigue has continued since it started on the 17th. Headaches last 30 seconds or a minute or two, then are gone, but return shortly after. Headache appears to be centered on the top of the head, slightly to the rear and to the left. It has not interfered with my sleep, as I am sleeping much more than normal.
Reoccurring headaches, chronic fatigue, dizziness and light headedness.  Received symptoms shortly after receiving first Anthrax vaccine on 23 July 2009. Doctor exempted from any further Anthrax vaccines.
pt recv vax 28JAN98 & 29JAN98 pt deltoid was inflamed & warm to touch w/a red, raise area approx 5 inches in size which spread down the arm below the inj site;31JAN98 pt recovered;
This spontaneous report as received from a Registered nurse refers to a 1 year old female patient with no drug reactions or allergies and no pertinent medical history. On 30-AUG-2012, the patient was vaccinated subcutaneously with first dose, 0.5 milliliter (ml) VARIVAX (Merck) single dose vaccination (Lot number was not provided). No concomitant medications were reported. On 11-SEP-2012 the patient returned to the practice with six varicella-like spots or lesions. The patient sought medical attention, office visit. No treatment was given. The nurse reported that the lesions had scabbed over by 12-SEP-2012. The outcome of the event was reported as recovering/resolving. Additional information has been requested.
11 YO receive Kinrix; the patient was supposed to receive Tdap not Kinrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-year-old female patient who received DTPa-IPV (Kinrix) (batch number H9FM5, expiry date 07-MAY-2023) for prophylaxis.  Previously administered products included DTaP and IPV (caught up with their DTaP and IPV series prior to receiving Kinrix).  On 25-APR-2023, the patient received Kinrix. On 25-APR-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 11 YO receive Kinrix) and wrong vaccine administered (Verbatim: the patient was supposed to receive Tdap not Kinrix). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.  This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional Information: GSK Receipt Date: 26-APR-2023 and 27-APR-2023 A healthcare professional called to inform that, a patient accidentally received a dose of Kinrix. Upon callback to Healthcare Professional (HCP) to review the medical information, it was determined that the patient was supposed to receive Tdap not Kinrix. The vaccine administration facility was the same as primary reporter. The reporter had consented to follow-up. The 11 year old patient was given Kinrix instead of Tdap vaccine which had led to wrong vaccine administered and inappropriate age at vaccine administration.
covid booster given 11/12 then to ER 11/16 for right leg pain, redness and diagnosed with phelebitis  and thrombophlebitis right lower extremity
Information has been received from a physician concerning his son who in approximately 1997 was vaccinated with varicella virus vaccine live (Oka/Merck). About two or three months after receiving varicella virus vaccine live, the patient had developed shingles. Subsequently, the patient recovered from shingles. Additional information has been requested.
Administered FLUZONE HD and ADACEL. Patient waiting in lobby, complained of numbness around mouth, dizziness, and tightness in chest. No difficulty swallowing or breathing. No treatment administered. After about 20 minutes patient left pharmacy with husband.
The patient has rendess, rash like reaction on the arm where she receive the shot, around 4 inches in diameter.  She also reported pain in her arm yesterday. Upon asking when she had the rash, she said she didn't notice it until yesterday (8/23/2020) when her arm hurt.